D83.9 Common variable immunodeficiency, unspecified

Name of the Condition

• Common variable immunodeficiency, unspecified

Summary

Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder marked by low levels of immunoglobulins (antibodies) in the blood, resulting in increased susceptibility to infections. This unspecified form of CVID lacks detailed classification of underlying immune abnormalities, such as predominant B-cell or T-cell disorders. It is one of the most common primary immunodeficiencies and can affect individuals of any age, with symptoms often emerging in early adulthood.

Causes

The exact cause of common variable immunodeficiency is often unknown, but it is believed to involve genetic and environmental factors. Mutations in genes related to B-cell development and function may contribute, though not all cases have a clear genetic link. Some cases may be associated with autoimmune disorders or malignancies due to immune dysregulation.

Risk Factors

• Family history of primary immunodeficiency disorders
• Presence of autoimmune conditions
• Increased risk of certain cancers, such as lymphoma
• Chronic infections or recurrent infections in childhood or adulthood

Symptoms

• Frequent and recurrent bacterial infections, particularly of the respiratory and gastrointestinal tracts
• Chronic sinusitis, bronchitis, or pneumonia
• Gastrointestinal issues, including diarrhea, malabsorption, or abdominal pain
• Fatigue and general weakness
• Enlarged lymph nodes or spleen
• Autoimmune manifestations, such as arthritis or cytopenias

Diagnosis

Diagnosis involves comprehensive blood tests to assess immunoglobulin (IgG, IgA, IgM) levels, which are typically low. Additional testing may include evaluating B-cell and T-cell function, as well as excluding other causes of immunodeficiency. Clinical history of recurrent infections and physical examination findings, such as enlarged lymph nodes or spleen, support the diagnosis.

Treatment Options

• Immunoglobulin replacement therapy to provide necessary antibodies
• Antibiotics to treat and prevent infections
• Management of autoimmune manifestations or malignancies if present
• Regular monitoring of immune function and infection risk

Prognosis and Follow-Up

Prognosis varies depending on the severity of infections and associated complications. With appropriate treatment, many individuals can lead relatively normal lives, though ongoing follow-up is essential to manage infections and monitor for autoimmune or malignant complications. Regular immunoglobulin level checks and clinical assessments are standard.

Complications

• Recurrent severe infections, including pneumonia or sepsis
• Autoimmune disorders, such as rheumatoid arthritis or immune thrombocytopenia
• Increased risk of certain cancers, particularly lymphoma
• Chronic lung disease from recurrent respiratory infections
• Malabsorption or gastrointestinal damage from persistent infections

Lifestyle & Prevention

• Practice good hygiene to reduce infection risk
• Stay up-to-date with vaccinations (as recommended by a healthcare provider)
• Avoid contact with individuals who have active infections
• Maintain a balanced diet to support overall health
• Avoid smoking, which can worsen respiratory complications

When to Seek Professional Help

Seek medical attention if experiencing frequent or severe infections, unexplained fatigue, persistent gastrointestinal symptoms, or signs of autoimmune disease. Early evaluation is crucial to initiate appropriate treatment and prevent complications.

Tips for Medical Coders

When coding for D83.9 (Common variable immunodeficiency, unspecified), ensure documentation supports the diagnosis of CVID without specifying B-cell or T-cell predominance. Verify that immunoglobulin levels and clinical history of recurrent infections are documented to confirm the unspecified classification. Avoid using this code if more specific details about immune abnormalities are available.